189 related articles for article (PubMed ID: 22819112)
1. Pioglitazone, a peroxisome proliferator activated receptor γ agonist, decreases renal crystal deposition, oxidative stress and inflammation in hyperoxaluric rats.
Taguchi K; Okada A; Yasui T; Kobayashi T; Ando R; Tozawa K; Kohri K
J Urol; 2012 Sep; 188(3):1002-11. PubMed ID: 22819112
[TBL] [Abstract][Full Text] [Related]
2. Atorvastatin inhibits renal crystal retention in a rat stone forming model.
Tsujihata M; Momohara C; Yoshioka I; Tsujimura A; Nonomura N; Okuyama A
J Urol; 2008 Nov; 180(5):2212-7. PubMed ID: 18804815
[TBL] [Abstract][Full Text] [Related]
3. Low-vitamin E diet exacerbates calcium oxalate crystal formation via enhanced oxidative stress in rat hyperoxaluric kidney.
Huang HS; Ma MC; Chen J
Am J Physiol Renal Physiol; 2009 Jan; 296(1):F34-45. PubMed ID: 18799548
[TBL] [Abstract][Full Text] [Related]
4. Pioglitazone decreased renal calcium oxalate crystal formation by suppressing M1 macrophage polarization via the PPAR-γ-miR-23 axis.
Chen Z; Yuan P; Sun X; Tang K; Liu H; Han S; Ye T; Liu X; Yang X; Zeng J; Yan L; Xing J; Xiao K; Ye Z; Xu H
Am J Physiol Renal Physiol; 2019 Jul; 317(1):F137-F151. PubMed ID: 31091119
[TBL] [Abstract][Full Text] [Related]
5. Chronic L-arginine administration increases oxidative and nitrosative stress in rat hyperoxaluric kidneys and excessive crystal deposition.
Huang HS; Ma MC; Chen J
Am J Physiol Renal Physiol; 2008 Aug; 295(2):F388-96. PubMed ID: 18448592
[TBL] [Abstract][Full Text] [Related]
6. The effects of PPAR-γ agonist pioglitazone on renal ischemia/reperfusion injury in rats.
Reel B; Guzeloglu M; Bagriyanik A; Atmaca S; Aykut K; Albayrak G; Hazan E
J Surg Res; 2013 Jun; 182(1):176-84. PubMed ID: 22981741
[TBL] [Abstract][Full Text] [Related]
7. Effect of pioglitazone, a peroxisome proliferator-activated receptor gamma agonist, on ischemia-reperfusion injury in rats.
Cao Z; Ye P; Long C; Chen K; Li X; Wang H
Pharmacology; 2007; 79(3):184-92. PubMed ID: 17356310
[TBL] [Abstract][Full Text] [Related]
8. Differential Roles of Peroxisome Proliferator-Activated Receptor-α and Receptor-γ on Renal Crystal Formation in Hyperoxaluric Rodents.
Taguchi K; Okada A; Hamamoto S; Unno R; Kobayashi T; Ando R; Tozawa K; Gao B; Kohri K; Yasui T
PPAR Res; 2016; 2016():9605890. PubMed ID: 27022389
[TBL] [Abstract][Full Text] [Related]
9. A peroxisome proliferator-activated receptor gamma agonist attenuates neurological deficits following spinal cord ischemia in rats.
Kim H; Hwang J; Park S; Nahm SF; Min S; Lim C; Park K; Han S
J Vasc Surg; 2014 Apr; 59(4):1084-9. PubMed ID: 23830318
[TBL] [Abstract][Full Text] [Related]
10. The peroxisome proliferator-activated receptor-γ agonist pioglitazone protects against cisplatin-induced renal damage in mice.
Jesse CR; Bortolatto CF; Wilhelm EA; Roman SS; Prigol M; Nogueira CW
J Appl Toxicol; 2014 Jan; 34(1):25-32. PubMed ID: 22987311
[TBL] [Abstract][Full Text] [Related]
11. Expression of inter-alpha inhibitor related proteins in kidneys and urine of hyperoxaluric rats.
Moriyama MT; Glenton PA; Khan SR
J Urol; 2001 May; 165(5):1687-92. PubMed ID: 11342956
[TBL] [Abstract][Full Text] [Related]
12. Preventive effects of green tea on renal stone formation and the role of oxidative stress in nephrolithiasis.
Itoh Y; Yasui T; Okada A; Tozawa K; Hayashi Y; Kohri K
J Urol; 2005 Jan; 173(1):271-5. PubMed ID: 15592095
[TBL] [Abstract][Full Text] [Related]
13. Pioglitazone attenuates diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats.
Ko GJ; Kang YS; Han SY; Lee MH; Song HK; Han KH; Kim HK; Han JY; Cha DR
Nephrol Dial Transplant; 2008 Sep; 23(9):2750-60. PubMed ID: 18388116
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin type-1 receptor blocker candesartan inhibits calcium oxalate crystal deposition in ethylene glycol-treated rat kidneys.
Yoshioka I; Tsujihata M; Akanae W; Nonomura N; Okuyama A
Urology; 2011 Apr; 77(4):1007.e9-1007.e14. PubMed ID: 21256551
[TBL] [Abstract][Full Text] [Related]
15. Modulatory effect of 4-phenyl butyric acid on hyperoxaluria-induced renal injury and inflammation.
Sharma M; Naura AS; Singla SK
Mol Cell Biochem; 2019 Jan; 451(1-2):185-196. PubMed ID: 30066041
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator-activated receptor-gamma agonists attenuate angiotensin II-induced collagen type I expression in adventitial fibroblasts.
Zhang J; Fang NY; Gao PJ; Wu LY; Han WQ; Guo SJ; Shen WL; Zhu DL
Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):72-7. PubMed ID: 18047631
[TBL] [Abstract][Full Text] [Related]
17. Matrix Gla protein is involved in crystal formation in kidney of hyperoxaluric rats.
Lu X; Gao B; Yasui T; Li Y; Liu T; Mao X; Hirose M; Wu Y; Yu D; Zhu Q; Kohri K; Xiao C
Kidney Blood Press Res; 2013; 37(1):15-23. PubMed ID: 23445897
[TBL] [Abstract][Full Text] [Related]
18. Study of a rat model for calcium oxalate crystal formation without severe renal damage in selected conditions.
Yamaguchi S; Wiessner JH; Hasegawa AT; Hung LY; Mandel GS; Mandel NS
Int J Urol; 2005 Mar; 12(3):290-8. PubMed ID: 15828958
[TBL] [Abstract][Full Text] [Related]
19. Reduction of renal lipid content and proteinuria by a PPAR-γ agonist in a rat model of angiotensin II-induced hypertension.
Sakamoto A; Hongo M; Saito K; Nagai R; Ishizaka N
Eur J Pharmacol; 2012 May; 682(1-3):131-6. PubMed ID: 22387860
[TBL] [Abstract][Full Text] [Related]
20. Minipump induced hyperoxaluria and crystal deposition in rats: a model for calcium oxalate urolithiasis.
Marengo SR; Chen D; MacLennan GT; Resnick MI; Jacobs GH
J Urol; 2004 Mar; 171(3):1304-8. PubMed ID: 14767338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
